Fifty 410 Review
Best for: Budget-focused buyers wanting transparent no-membership compounded GLP-1 pricing
Fifty 410 is a direct-to-consumer weight-loss telehealth service offering personalized compounded semaglutide and tirzepatide prescribed by licensed providers and prepared by FDA-registered 503A and 503B pharmacies. It uses a no-membership, pay-as-you-go model with transparent public pricing: semaglutide from 99 dollars per month and tirzepatide starter from 133 dollars per month, plus a high-dose tier. Provider reviews finish in 24 to 48 hours and free shipping arrives in one to two days. Cash-pay only; no direct insurance billing, but accepts FSA/HSA, Afterpay, and Affirm.
Medium confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Fifty 410 is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Fifty 410 prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Flat-rate (all doses) | compounded | $99 |
| Starter | compounded | $133 |
✓ Pros
- •Transparent public pricing from 99 dollars per month for semaglutide
- •No membership or subscription; pay only for what you need
- •Compounded by FDA-registered 503A and 503B pharmacies
- •Fast 24 to 48 hour provider review
- •Free one to two day shipping
- •Accepts FSA/HSA plus Afterpay and Affirm
✗ Cons
- •Does not bill insurance directly
- •Compounded GLP-1 is not an FDA-approved finished drug
- •Specific clinician credentials are not publicly disclosed
- •Served-states list is not published on the site
- •No branded GLP-1 options
Ready to start with Fifty 410?
Starting at $99/month. See current pricing and start your free consultation.
Sources & methodology
Our Fifty 410 review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Fifty 410
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Fifty 410?
Starting at $99/month. See current pricing and start your free consultation.